Lifevantage Corp

Listed Company
LFVNCIK 0000849146NasdaqAcceleratedSmaller ReportingPharmaceutical PreparationsFY ends Jun 30
Period
FY 2025
Revenue
$228.53M
Net Income
$9.80M
Total Assets
$71.96M
Equity
$34.64M
Shares Out
12.79M
Op. Cash Flow
$11.88M

Business

LifeVantage Corp focuses on nutrigenomics, researching how nutrition and natural compounds affect gene expression to support health and wellness. It develops, formulates and sells dietary supplements, weight management products, pre- and pro-biotics, skin and hair care, pet supplements, and nootropic energy drink mixes under brands such as Protandim®, LifeVantage®, TrueScience®, PhysIQ™, Petandim®, and AXIO®. The company operates a direct selling business model built around independent consultants, supported by research and technology-enabled consultant training and loyalty programs. It distributes products primarily via independent consultants, company websites, subscription services and select international customer-only channels across the Americas, Asia/Pacific and Europe.

Summary from filing dated 2025-09-04

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts
ConceptTrend
FY 2025
2025-06-30
FY 2024
2024-06-30
FY 2023
2023-06-30
FY 2022
2022-06-30
FY 2021
2021-06-30
Revenue, net229200213206220
Cost of sales4541433838
Gross profit184159170168182
Commissions and incentives102869597104
Selling, general and administrative6968716361
Total operating expenses171154166161164
Operating income1244818
Interest income, net431,000430,000
Other expense, net−387,000−412,000−458,000−669,000−366,000
Total other income, net44,00018,000−260,000−3−383,000
Income before income taxes1244517
Income tax expense−2−1−1−2−4
Net income1033313
Basic (dollars per share)0.80.240.20.240.92
Diluted (dollars per share)0.750.230.20.240.9
Basic (in shares)1212131314
Diluted (in shares)1313131314
Foreign currency translation adjustment741,000−555,000−238,000−1−40,000
Other comprehensive income (loss), net of tax:741,000−555,000−238,000−1−40,000
Comprehensive income1122213

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro